DNTH Dianthus Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 4, 2026
$88,21
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$32,2252 haftanın en düşüğü
$117,8852 haftanın en yükseği
Piyasa Değeri (MRQ)
$4.83B
P/E
-21.0
Hisse Başına Kâr
$-4.20
Gelir
$2M
rozetleriniz
52 Haftlık Aralık
$32–$118
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$141
P/E
-21.0
ROE
-40.8%
Net Kâr Marjı
-7973.3%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
DNTH Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$88.21
Piyasa Değeri (MRQ)
$4.83B
P/E
-21.0
Hisse Başına Kâr
$-4.20
Gelir
$2M
ROE
-40.8%
52 Haftlık Aralık
$32–$118
DNTH Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Dianthus Therapeutics, Inc. - Common Stock Hakkında Wikipedia'dan şirket genel bakışı
sektörHealthcare
endüstriBiotechnology
çalışanlar92
ülkeUS
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$2M2016-12-31 → 2025-12-31
Hisse Başına Kâr$-4.202020-12-31 → 2025-12-31
Serbest Nakit Akışı·2018-12-31 → 2021-12-31
Net kar marjı-7973.3%2024-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | DNTH | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E | -21.05Y ort. ≈-14.9 | ≈-14.9 | · | · | |
| P/S (F/S) | 1872.65Y ort. ≈346.1 | ≈346.1 | 55.0 | Aşırı değerli | |
| F/D (MRQ) | 4.15Y ort. ≈7.6 | ≈7.6 | 8.1 | Düşük değerli | |
| Price / Cash Flow (Fiyat / Nakit Akışı) | -29.55Y ort. ≈-24.2 | ≈-24.2 | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 7.75Y ort. ≈2.1 | ≈2.1 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | DNTH | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Operating Margin (Faaliyet Kâr Marjı) | -8739.3% | · | -101.3% | Zayıf | |
| EBITDA Margin (FAVÖK Marjı) | -8739.3% | · | -101.3% | Zayıf | |
| Net Profit Margin (Net Kâr Marjı) | -7973.3% | · | -100.5% | Zayıf | |
| ROA | -35.9%5Y ort. ≈-35.1% | ≈-35.1% | -28.1% | Zayıf | |
| ROE | -40.8%5Y ort. ≈-32.4% | ≈-32.4% | -41.5% | Aynı seviyede |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | DNTH | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 26.15Y ort. ≈15.9 | ≈15.9 | 6.5 | Güçlü likidite | |
| Cari Oran (MRQ) | 25.85Y ort. ≈15.6 | ≈15.6 | 2.9 | Güçlü likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | DNTH | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | -67.3% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | DNTH | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.0 | · | 0.2 | Zayıf | |
| Receivables Turnover (Alacak Devir Hızı) | 78.3 | · | 9.7 | En üst düzey | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$22.1K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-2.5%
Sonraki Rapor
Kas 03, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 6, 2026 | $-0.90 | $-0.87 | -2.9% |
| 31 Mart 2026 | May 11, 2026 | $-0.85 | $-1.09 | 22.3% |
| 31 Aralık 2025 | $-1.43 | $-1.10 | -30.3% | |
| 30 Eylül 2025 | $-0.97 | $-0.88 | -10.3% | |
| 30 Haziran 2025 | $-0.88 | $-0.89 | 1.0% | |
| 31 Mart 2025 | $-0.82 | $-0.87 | 5.3% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $6M | $3M | · | · | · | $0 | $0 | $0 | |
| R&D Expense | $146M | $83M | $33M | $29M | $47M | $51M | $59M | $41M | $28M | |
| SG&A Expense | $34M | $25M | $18M | $7M | $28M | $28M | $24M | $19M | $8M | |
| Operating Expenses | $180M | $108M | $51M | $36M | $75M | $79M | $83M | $60M | $36M | |
| Operating Income | $-178M | $-102M | $-48M | $-30M | $-75M | $-79M | $-83M | $-60M | $-36M | |
| Interest Income | $16M | $17M | $5M | · | · | · | · | · | · | |
| Other Non-op | $-974.0K | $-554.0K | $-60.0K | $-52.0K | · | · | · | $2M | $236.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-162M | $-85M | $-44M | $-28M | $-71M | $-75M | $-77M | $-58M | $-35M | |
| EPS (Basic) | $-4.20 | $-2.55 | $-8.45 | $-32.57 | $-1.29 | $-1.71 | · | · | · | |
| EPS (Diluted) | $-4.20 | $-2.55 | $-8.45 | $-32.57 | $-1.29 | $-1.71 | · | · | · | |
| Shares (Basic) | 38,617,580 | 33,313,849 | 5,153,423 | 874,234 | 54,948,808 | 43,920,121 | · | · | · | |
| Shares (Diluted) | 38,617,580 | 33,313,849 | 5,153,423 | 874,234 | 54,948,808 | 43,920,121 | · | · | · | |
| EBITDA | $-178M | $-102M | $-48M | · | $-73M | $-77M | $-81M | $-59M | · |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $51M | $23M | $132M | $15M | $132M | $58M | $65M | $58M | $51M | |
| Short-term Investments | $353M | $252M | $41M | $60M | $45M | $91M | $81M | $84M | · | |
| Receivables | $52.0K | $0 | $294.0K | $5M | · | · | · | · | · | |
| Prepaid Expense | $5M | $5M | $3M | $905.0K | $4M | $3M | $4M | $3M | $936.0K | |
| Other Current Assets | $86.0K | $355.0K | $0 | · | · | · | · | · | · | |
| Current Assets | $409M | $281M | $177M | $82M | $181M | $152M | $150M | $145M | $53M | |
| PP&E (Net) | $296.0K | $194.0K | $185.0K | $142.0K | $7M | $8M | $10M | $10M | $2M | |
| PP&E (Gross) | $600.0K | $387.0K | $282.0K | $172.0K | $14M | $13M | $13M | $11M | $2M | |
| Accum. Depreciation | $304.0K | $193.0K | $97.0K | $30.0K | $7M | $5M | $3M | $1M | $382.0K | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | $4.0K | |
| Total Assets | $531M | $374M | $179M | $83M | $190M | $162M | $162M | $157M | $54M | |
| Accounts Payable | $10M | $5M | $3M | $1M | $3M | $4M | $3M | $3M | $167.0K | |
| Accrued Liabilities | $19M | $13M | $7M | $7M | $8M | $8M | $11M | $7M | $4M | |
| Current Liabilities | $31M | $18M | $10M | $8M | $11M | $11M | $14M | $10M | $4M | |
| Capital Leases | $1M | $1M | $168.0K | $438.0K | $0 | · | · | · | · | |
| Total Liabilities | $38M | $22M | $11M | $9M | $17M | $18M | $20M | $12M | $4M | |
| Common Stock | $43.0K | $31.0K | $15.0K | $0 | $59.0K | $49.0K | $39.0K | $33.0K | $2.0K | |
| Retained Earnings | $-337M | $-174M | $-89M | $-46M | $-326M | $-254M | $-179M | $-103M | $-45M | |
| AOCI | $489.0K | $106.0K | $47.0K | $-161.0K | $-30.0K | $-23.0K | $8.0K | $-8.0K | · | |
| Stockholders' Equity | $493M | $352M | $169M | $-44M | $-17M | $144M | $141M | $146M | $-42M | |
| Liabilities + Equity | $531M | $374M | $179M | $83M | $190M | $162M | $162M | $157M | $54M | |
| Shares Outstanding | 43,223,090 | 31,115,341 | 14,817,696 | 875,279 | 58,799,157 | 48,533,135 | 39,260,532 | 33,305,033 | 2,351,247 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | $2M | $2M | $2M | $2M | $875.0K | $376.0K | |
| Stock-based Comp | $23M | $13M | $3M | $2M | $10M | $10M | $10M | $11M | $2M | |
| Other Non-cash | · | · | · | · | $-723.0K | $-1M | $8M | $4M | · | |
| Operating Cash Flow | $-129M | $-78M | $-37M | $-29M | $-60M | $-64M | $-57M | $-42M | $-22M | |
| CapEx | · | · | · | $314.0K | $1M | $400.0K | $3M | $8M | $2M | |
| Investing Cash Flow | $-123M | $-287M | $20M | $-60M | $43M | $-11M | $2M | $-92M | $-2M | |
| Stock Issued | $317.0K | $0 | $0 | $3M | $0 | $65M | $61M | $93M | · | |
| Net Stock Activity | $317.0K | $39M | · | · | · | $65M | $61M | · | · | |
| Financing Cash Flow | $280M | $256M | $134M | $97M | $90M | $68M | $62M | $142M | $71M | |
| Net Change in Cash | $28M | $-109M | $117M | $8M | $73M | $-7M | $7M | $9M | $47M | |
| Taxes Paid | $0 | $0 | $0 | $0 | · | · | · | · | · | |
| Free Cash Flow | · | · | · | · | $-61M | $-64M | $-60M | $-50M | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -8739.3% | -1633.7% | · | · | · | · | · | · | · | |
| Net Margin | -7973.3% | -1362.8% | · | · | · | · | · | · | · | |
| EBITDA Margin | -8739.3% | -1633.7% | · | · | · | · | · | · | · | |
| ROA | -35.9% | -30.7% | -33.2% | · | -40.5% | -46.4% | -48.2% | -54.3% | · | |
| ROE | -40.8% | -24.6% | -25.1% | · | -39.3% | -49.5% | -50.7% | -37.7% | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 13.3 | 15.2 | 18.4 | · | 16.6 | 13.3 | 10.6 | 13.9 | · | |
| Quick Ratio | 13.2 | 15.0 | 18.1 | · | 16.3 | 13.0 | 10.3 | 13.7 | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | · | · | · | 0.0 | 0.0 | · | |
| Receivables Turnover | 78.3 | 11.3 | · | · | · | · | · | · | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $11.42 | $11.33 | $11.40 | · | $2.94 | $2.97 | $3.60 | $4.37 | · | |
| Revenue / Share | $0.05 | $0.19 | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-3.34 | $-2.35 | $-7.15 | · | $-1.08 | · | · | · | · | |
| Cash / Share | $1.18 | $0.73 | $8.93 | · | $2.24 | $1.20 | $1.66 | $1.75 | · | |
| Dividend / Share | $0.00 | $0.00 | $0.00 | · | · | · | · | · | · | |
| EPS (TTM) | $-4.20 | $-2.55 | $-8.45 | $-32.57 | $-1.29 | $-1.71 | · | · | · |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -67.3% | 120.6% | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $6M | $3M | · | $0 | $0 | $0 | $0 | · | |
| Net Income TTM | $-162M | $-85M | $-44M | $-28M | $-71M | $-75M | $-77M | $-58M | · | |
| Market Cap | $1.78B | $678M | $154M | · | $4.17B | $6.09B | $9.52B | $3.04B | · | |
| P/E | -9.8 | -8.5 | -1.2 | -0.2 | -54.9 | -73.4 | · | · | · | |
| P/S | 874.9 | 108.8 | 54.5 | · | · | · | · | · | · | |
| P/B | 3.6 | 1.9 | 0.9 | · | 24.1 | 42.3 | 67.4 | 20.9 | · | |
| P / Tangible Book | 3.6 | 1.9 | 0.9 | · | · | 42.3 | · | · | · | |
| P / Cash Flow | -13.8 | -8.7 | -4.2 | · | -70.0 | -95.1 | -166.8 | -72.5 | · | |
| P / FCF | · | · | · | · | -68.6 | -94.5 | -158.3 | -61.3 | · | |
| Earnings Yield | -10.2% | -11.7% | -81.2% | -508.9% | -1.8% | -1.4% | · | · | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $284.0K | $396.0K | $193.0K | $1M | $1M | $2M | $2M | $874.0K | $457.0K | $924.0K | · | · | · | $1M | |
| R&D Expense | $49M | $35M | $60M | $32M | $26M | $27M | $26M | $26M | $18M | $13M | $9M | $8M | $10M | $6M | $-6M | $7M | |
| SG&A Expense | $14M | $12M | $10M | $8M | $9M | $7M | $7M | $7M | $6M | $6M | $5M | $9M | $2M | $2M | $-9M | $2M | |
| Operating Expenses | $62M | $47M | $70M | $41M | $35M | $34M | $33M | $32M | $24M | $19M | $13M | $17M | $13M | $8M | $-15M | $9M | |
| Operating Income | $-61M | $-47M | $-70M | $-40M | $-35M | $-33M | $-32M | $-30M | $-22M | $-18M | $-13M | $-16M | $-12M | $-8M | $20M | $-8M | |
| Interest Income | $12M | $6M | $11M | $1M | $3M | $4M | $7M | $2M | $4M | $4M | · | · | · | · | · | · | |
| Other Non-op | $-370.0K | $-249.0K | $-409.0K | $-360.0K | $-107.0K | $-98.0K | $-382.0K | $22.0K | $-80.0K | $-114.0K | $-19.0K | $-15.0K | $-23.0K | $-3.0K | $-43.0K | $-2.0K | |
| Net Income | $-50M | $-41M | $-64M | $-37M | $-32M | $-30M | $-28M | $-25M | $-18M | $-14M | $-11M | $-15M | $-11M | $-7M | $-10M | $-8M | |
| EPS (Basic) | $-0.90 | $-0.85 | $-1.53 | $-0.97 | $-0.88 | $-0.82 | $-0.76 | $-0.74 | $-0.51 | $-0.54 | $16.16 | $-3.78 | $-12.73 | $-8.10 | $-22.99 | $-8.90 | |
| EPS (Diluted) | $-0.90 | $-0.85 | $-1.53 | $-0.97 | $-0.88 | $-0.82 | $-0.76 | $-0.74 | $-0.51 | $-0.54 | $16.16 | $-3.78 | $-12.73 | $-8.10 | $-22.99 | $-8.90 | |
| Shares (Basic) | 56,029,124 | 48,032,742 | · | 37,794,088 | 35,822,308 | 35,790,700 | · | 34,236,728 | 34,227,038 | 25,665,475 | · | 3,906,886 | 874,900 | 874,709 | · | 874,327 | |
| Shares (Diluted) | 56,029,124 | 48,032,742 | · | 37,794,088 | 35,822,308 | 35,790,700 | · | 34,236,728 | 34,227,038 | 25,665,475 | · | 3,906,886 | 874,900 | 874,709 | · | 874,327 | |
| EBITDA | $-61M | $-47M | · | $-40M | $-35M | $-33M | · | $-30M | $-22M | $-18M | · | $-16M | $-7M | $-32M | · | $-17M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $111M | $628M | $51M | $56M | $13M | $10M | $23M | $34M | $314M | $330M | $132M | $157M | $63M | $49M | $15M | $59M | |
| Short-term Investments | $776M | $484M | $353M | $347M | $244M | $253M | $252M | $247M | $47M | $47M | $41M | $33M | · | · | $60M | $69M | |
| Receivables | $106.0K | $1M | $52.0K | $5M | $39.0K | $1M | $0 | $1M | $840.0K | $435.0K | $294.0K | $232.0K | · | · | $5M | · | |
| Prepaid Expense | $11M | $7M | $5M | $6M | $6M | $7M | $5M | $4M | $3M | $3M | $3M | $832.0K | $1M | $3M | $905.0K | $4M | |
| Other Current Assets | $184.0K | $83.0K | $86.0K | $73.0K | $111.0K | $392.0K | $355.0K | · | · | · | $0 | · | · | · | · | · | |
| Current Assets | $898M | $1.12B | $409M | $414M | $264M | $271M | $281M | $287M | $366M | $381M | $177M | $191M | $79M | $83M | $82M | $132M | |
| PP&E (Net) | $418.0K | $274.0K | $296.0K | $185.0K | $207.0K | $191.0K | $194.0K | $189.0K | $189.0K | $195.0K | $185.0K | $195.0K | $0 | $0 | $142.0K | $6M | |
| PP&E (Gross) | $791.0K | $610.0K | $600.0K | $462.0K | $457.0K | $411.0K | $387.0K | $356.0K | $331.0K | $314.0K | $282.0K | $272.0K | · | · | $172.0K | · | |
| Accum. Depreciation | $373.0K | $336.0K | $304.0K | $277.0K | $250.0K | $220.0K | $193.0K | $167.0K | $142.0K | $119.0K | $97.0K | $77.0K | · | · | $30.0K | · | |
| Total Assets | $1.21B | $1.25B | $531M | $577M | $326M | $349M | $374M | $354M | $369M | $382M | $179M | $192M | $79M | $83M | $83M | $164M | |
| Accounts Payable | $6M | $5M | $10M | $7M | $5M | $8M | $5M | $8M | $4M | $3M | $3M | $1M | $813.0K | $1M | $1M | $3M | |
| Accrued Liabilities | $26M | $31M | $19M | $16M | $14M | $8M | $13M | $8M | $6M | $6M | $7M | $11M | · | · | $7M | $7M | |
| Current Liabilities | $34M | $38M | $31M | $24M | $20M | $17M | $18M | $16M | $10M | $9M | $10M | $13M | $4M | $6M | $8M | $13M | |
| Capital Leases | $913.0K | $965.0K | $1M | $1M | $1M | $1M | $1M | $0 | $30.0K | $97.0K | $168.0K | $257.0K | $0 | $0 | $438.0K | $27M | |
| Total Liabilities | $41M | $46M | $38M | $31M | $23M | $20M | $22M | $16M | $11M | $10M | $11M | $14M | $4M | $6M | $9M | $40M | |
| Common Stock | $55.0K | $54.0K | $43.0K | $43.0K | $32.0K | $32.0K | $31.0K | $29.0K | $29.0K | $29.0K | $15.0K | $15.0K | $61.0K | $61.0K | $0 | $61.0K | |
| Retained Earnings | $-428M | $-378M | $-337M | $-272M | $-236M | $-204M | $-174M | $-146M | $-121M | $-103M | $-89M | $-79M | $-434M | $-431M | $-46M | $-382M | |
| AOCI | $-2M | $-575.0K | $489.0K | $163.0K | $98.0K | $270.0K | $106.0K | $681.0K | $-37.0K | $-27.0K | $47.0K | $-4.0K | $-3.0K | $-16.0K | $-161.0K | $-462.0K | |
| Stockholders' Equity | $1.17B | $1.20B | $493M | $546M | $303M | $329M | $352M | $338M | $358M | $373M | $169M | $178M | $75M | $77M | $-44M | $124M | |
| Liabilities + Equity | $1.21B | $1.25B | $531M | $577M | $326M | $349M | $374M | $354M | $369M | $382M | $179M | $192M | $79M | $83M | $83M | $164M | |
| Shares Outstanding | 54,798,338 | 54,582,749 | 43,223,090 | 42,854,563 | 32,176,482 | 32,125,933 | 31,115,341 | 29,366,352 | 29,352,140 | 29,348,626 | 14,817,696 | 14,817,762 | 60,652,197 | 60,648,821 | 875,279 | 60,555,520 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $421.0K | · | $471.0K | |
| Stock-based Comp | $12M | $11M | $6M | $6M | $6M | $5M | $4M | $4M | $3M | $2M | $726.0K | $1M | $489.0K | $533.0K | $513.0K | $-3M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | · | · | $2M | $18M | · | · | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | · | · | · | · | $-7M | · | · | |
| Operating Cash Flow | $-49M | $-29M | $-47M | $-31M | $-24M | $-28M | $-27M | $-21M | $-15M | $-15M | $-12M | $17M | $21M | $-10M | $-9M | $16M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $245.0K | · | $158.0K | |
| Investing Cash Flow | $-479M | $-134M | $37M | $-201M | $26M | $15M | $-23M | $-259M | $1M | $-6M | $-8M | $-17M | $13M | $18M | $-13M | $-7M | |
| Stock Issued | $0 | $120.0K | $1.0K | $187.0K | $0 | $129.0K | $0 | $0 | $0 | $0 | · | · | · | · | · | · | |
| Net Stock Activity | · | $120.0K | · | · | · | $129.0K | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $10M | $739M | $5M | $275M | $568.0K | $161.0K | $40M | $296.0K | $-2M | $218M | $-5M | $138M | $0 | $0 | $0 | $97M | |
| Net Change in Cash | $-517M | $577M | $-5M | $43M | $3M | $-13M | $-11M | $-280M | $-16M | $197M | $-25M | $139M | $34M | $8M | $-22M | $106M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | $0 | $0 | · | · | $0 | $0 | · | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | $-36M | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | -10173.7% | -18096.9% | -2852.7% | · | · | · | · | · | -1705.5% | · | · | · | · | |
| Net Margin | · | · | · | -9284.1% | -16388.1% | -2537.5% | · | · | · | · | · | -1597.7% | · | · | · | · | |
| EBITDA Margin | · | · | · | -10173.7% | -18096.9% | -2852.7% | · | · | · | · | · | -1705.5% | · | · | · | · | |
| ROA | -6.5% | -5.1% | · | -7.9% | -9.1% | -8.1% | · | -9.2% | -7.9% | -5.9% | · | -8.3% | -2.6% | -21.0% | · | -8.7% | |
| ROE | -6.8% | -5.3% | · | -8.3% | -9.6% | -8.4% | · | -9.8% | -8.1% | -6.1% | · | -9.8% | -3.1% | -25.5% | · | -10.2% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 26.1 | 29.3 | · | 17.3 | 13.1 | 16.0 | · | 18.3 | 36.5 | 42.5 | · | 14.6 | 19.5 | 13.9 | · | 10.2 | |
| Quick Ratio | 25.8 | 29.1 | · | 17.1 | 12.8 | 15.6 | · | 18.0 | 36.1 | 42.1 | · | 14.5 | 15.5 | 8.1 | · | 9.9 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.0 | 0.0 | · | · | · | · | · | 0.0 | · | · | · | · | |
| Receivables Turnover | · | · | · | 0.1 | 0.4 | 1.6 | · | · | · | · | · | 8.0 | · | · | · | · |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $21.39 | $22.01 | · | $12.75 | $9.42 | $10.23 | · | $11.51 | $12.20 | $12.70 | · | $12.04 | $1.23 | $1.28 | · | $2.05 | |
| Revenue / Share | · | · | · | $0.01 | $0.01 | $0.03 | · | · | · | · | · | $0.24 | · | · | · | · | |
| Cash Flow / Share | · | $-0.60 | · | · | · | $-0.77 | · | · | · | $-0.58 | · | · | · | $-0.59 | · | · | |
| Cash / Share | $2.02 | $11.50 | · | $1.31 | $0.41 | $0.31 | · | $1.15 | $10.70 | $11.23 | · | $10.61 | $1.03 | $0.80 | · | $0.97 | |
| Dividend / Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | · | · | · | · | · | |
| EPS (TTM) | $-4.25 | $-4.23 | · | $-3.43 | $-3.20 | $-2.83 | · | $14.37 | $11.33 | $-0.89 | · | $-47.60 | $-52.72 | $-40.28 | · | $-9.89 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $2M | · | $3M | $5M | $7M | · | $5M | $4M | · | · | · | · | · | · | · | |
| Net Income TTM | $-192M | $-174M | · | $-126M | $-115M | $-101M | · | $-67M | $-57M | $-50M | · | $-43M | $-36M | $-31M | · | $-38M | |
| Market Cap | $5.34B | $4.58B | · | $1.69B | $599M | $583M | · | $804M | $760M | $880M | · | $203M | $738M | $767M | · | $1.37B | |
| P/E | -22.9 | -19.8 | · | -11.5 | -5.8 | -6.4 | · | 1.9 | 2.3 | -33.7 | · | -0.3 | -0.2 | -0.3 | · | -2.3 | |
| P/S | 2623.6 | 2249.8 | · | 547.9 | 123.5 | 89.3 | · | 149.8 | 184.5 | · | · | · | · | · | · | · | |
| P/B | 4.6 | 3.8 | · | 3.1 | 2.0 | 1.8 | · | 2.4 | 2.1 | 2.4 | · | 1.1 | 9.9 | 9.9 | · | 11.0 | |
| P / Tangible Book | 4.6 | 3.8 | · | 3.1 | 2.0 | 1.8 | · | 2.4 | 2.1 | 2.4 | · | 1.1 | 9.9 | 9.9 | · | 11.0 | |
| P / Cash Flow | · | -158.7 | · | · | · | -21.1 | · | · | · | -58.9 | · | · | · | -21.5 | · | · | |
| Earnings Yield | -4.4% | -5.0% | · | -8.7% | -17.2% | -15.6% | · | 52.5% | 43.8% | -3.0% | · | -348.2% | -433.5% | -318.7% | · | -43.8% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $2M | $6M | $3M | · | · |
| Faaliyet Kâr Marjı % | -8739.3% | -1633.7% | · | · | · |
| Net Gelir | $-162M | $-85M | $-44M | $-28M | $-71M |
| Seyreltilmiş Hisse Başı Kâr | $-4.20 | $-2.55 | $-8.45 | $-32.57 | $-1.29 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Cari Oran | 13.3 | 15.2 | 18.4 | · | 16.6 |
| Cari Oran | 13.2 | 15.0 | 18.1 | · | 16.3 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | · | · | · | · | $-61M |
Kurumsal Sahipler (13F) 284 dosya · $5.9B toplam · Tarih itibarıyla 30 Eylül 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
284
Tutulan Değer
$5.9B
Yeni pozisyonlar
61
Çıkan pozisyonlar
31
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 61 (-43 önceki Ç'ye göre) | 31 (+14 önceki Ç'ye göre) | 121 (+38 önceki Ç'ye göre) | 67 (+14 önceki Ç'ye göre) | +4.7M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| FMR LLC | $799.325.570 | 8.199.893 | 13,66% | Hisse senetleri |
| BlackRock, Inc. | $401.990.169 | 4.123.822 | 6,87% | Hisse senetleri |
| WELLINGTON MANAGEMENT GROUP LLP | $314.848.897 | 3.229.882 | 5,38% | Hisse senetleri |
| Fairmount Funds Management LLC | $247.325.379 | 2.537.191 | 4,23% | Hisse senetleri |
| STATE STREET CORP | $229.798.634 | 2.357.440 | 3,93% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $210.514.689 | 2.159.568 | 3,60% | Hisse senetleri |
| Avidity Partners Management LP | $205.115.856 | 2.104.184 | 3,50% | Hisse senetleri |
| Octagon Capital Advisors LP | $179.525.699 | 1.841.667 | 3,07% | Hisse senetleri |
| TCG Crossover Management, LLC | $163.437.308 | 1.676.624 | 2,79% | Hisse senetleri |
| FRED ALGER MANAGEMENT, LLC | $126.967.018 | 1.302.493 | 2,17% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $122.696.604 | 1.258.502 | 2,10% | Hisse senetleri |
| Venrock Adviser, LLC | $115.026.400 | 1.180.000 | 1,97% | Hisse senetleri |
| UBS Group AG | $111.152.545 | 1.140.260 | 1,90% | Hisse senetleri |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $109.695.511 | 1.125.313 | 1,87% | Hisse senetleri |
| JENNISON ASSOCIATES LLC | $99.601.453 | 1.021.763 | 1,70% | Hisse senetleri |
| Polar Capital Holdings Plc | $99.305.410 | 1.018.726 | 1,70% | Hisse senetleri |
| CITADEL ADVISORS LLC | $95.034.324 | 974.911 | 1,62% | Hisse senetleri |
| FRANKLIN RESOURCES INC | $94.456.440 | 968.983 | 1,61% | Hisse senetleri |
| VANGUARD GROUP INC | $84.416.707 | 2.048.452 | 1,44% | Hisse senetleri |
| BAKER BROS. ADVISORS LP | $83.068.947 | 852.164 | 1,42% | Hisse senetleri |
| Logos Global Management LP | $77.984.000 | 800.000 | 1,33% | Hisse senetleri |
| Cormorant Asset Management, LP | $73.110.000 | 750.000 | 1,25% | Hisse senetleri |
| ALLIANCEBERNSTEIN L.P. | $70.001.868 | 834.150 | 1,20% | Hisse senetleri |
| BRAIDWELL LP | $57.957.904 | 594.562 | 0,99% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $55.574.810 | 570.115 | 0,95% | Hisse senetleri |
| AMERIPRISE FINANCIAL INC | $51.859.546 | 531.999 | 0,89% | Hisse senetleri |
| Woodline Partners LP | $48.793.419 | 500.548 | 0,83% | Hisse senetleri |
| BARCLAYS PLC | $42.087.284 | 431.753 | 0,72% | Hisse senetleri |
| MPM BIOIMPACT LLC | $40.941.795 | 420.002 | 0,70% | Hisse senetleri |
| NORTHERN TRUST CORP | $40.141.386 | 411.791 | 0,69% | Hisse senetleri |
| Affinity Asset Advisors, LLC | $38.992.000 | 400.000 | 0,67% | Hisse senetleri |
| SILVERARC CAPITAL MANAGEMENT, LLC | $38.017.200 | 390.000 | 0,65% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $37.253.054 | 382.161 | 0,64% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $35.674.073 | 365.963 | 0,61% | Hisse senetleri |
| Bain Capital Life Sciences Investors, LLC | $35.333.576 | 362.470 | 0,60% | Hisse senetleri |
| Spruce Street Capital LP | $34.587.464 | 354.816 | 0,59% | Hisse senetleri |
| Vivo Capital, LLC | $34.507.725 | 353.998 | 0,59% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $31.334.301 | 321.503 | 0,54% | Hisse senetleri |
| WESTFIELD CAPITAL MANAGEMENT CO LP | $30.697.817 | 314.914 | 0,52% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $29.485.945 | 302.482 | 0,50% | Hisse senetleri |
| Driehaus Capital Management LLC | $28.782.530 | 295.266 | 0,49% | Hisse senetleri |
| First Turn Management, LLC | $27.856.957 | 285.771 | 0,48% | Hisse senetleri |
| Assenagon Asset Management S.A. | $27.357.665 | 280.649 | 0,47% | Hisse senetleri |
| TANG CAPITAL MANAGEMENT LLC | $25.802.176 | 264.692 | 0,44% | Hisse senetleri |
| Artisan Partners Limited Partnership | $25.176.062 | 258.269 | 0,43% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $25.036.081 | 256.833 | 0,43% | Hisse senetleri |
| Bank of New York Mellon Corp | $24.993.153 | 256.393 | 0,43% | Hisse senetleri |
| RTW INVESTMENTS, LP | $24.181.181 | 248.063 | 0,41% | Hisse senetleri |
| EMERALD ADVISERS, LLC | $24.156.031 | 247.805 | 0,41% | Hisse senetleri |
| Pictet Asset Management Holding SA | $24.106.317 | 247.295 | 0,41% | Hisse senetleri |
Aktivistler ve %5+ sahipler 4 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Fairmount Funds Management LLC, Fairmount Healthcare Fund II L.P., Peter Evan Harwin, Tomas Kiselak ×5 başvurular | 25 Kasım 2025 | 4,90% | Değişiklik | · | SEC |
| Avidity Partners Management LP, Avidity Partners Management (GP) LLC, Avidity Capital Partners Fund (GP) LP, Avidity Capital Partners (GP) LLC, Avidity Private Master Fund I LP, Michael Gregory ×4 başvurular | 19 Kasım 2025 | 4,90% | Değişiklik | Pasif yatırım | SEC |
| Viridian, LLC ×2 başvurular | 12 Eylül 2024 | · | İlk başvuru | · | SEC |
| ATLAS VENTURE FUND X, L.P., ATLAS VENTURE ASSOCIATES X, L.P., Atlas Venture Associates X, LLC, Atlas Venture Opportunity Fund I, L.P., Atlas Venture Associates Opportunity I, L.P., Atlas Venture Associates Opportunity I, LLC ×4 başvurular | 15 Eylül 2023 | · | İlk başvuru | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 36 içeriden öğrenenler · 13 yöneticiler · 17 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Marino Garcia | CEO AND PRESIDENT | 07 Ağustos 2026 M | 65.292 | 0 | 12 | $-27.961.831 |
| Ryan Savitz | EVP, CFO & CBO | 09 Temmuz 2026 M | 0 | 0 | 13 | $-14.292.190 |
| Edward Carr | CHIEF ACCOUNTING OFFICER | 17 Eylül 2026 M | 0 | 0 | 10 | $-5.587.140 |
| Simrat Randhawa | EVP, Head of R&D | 01 Eylül 2026 M | 4.000 | 0 | 11 | $-15.001.124 |
| Adam M Veness | SVP, General Counsel and Sec. | 13 Ağustos 2026 M | 15.000 | 0 | 5 | $-4.632.790 |
| David Wayne Nichols | Chief Technical Officer | 01 Ağustos 2022 A | 14.306 | 0 | 0 | $0 |
| Lisa Olson | Title: Head of Research and Chief Scientific Officer Exhibit 24.1: Power of Attorney | 01 Ağustos 2022 A | 14.264 | 0 | 0 | $0 |
| Jeffrey Humphrey | Chief Medical Officer | 01 Ağustos 2022 A | · | 0 | 0 | $0 |
| John C. Davis JR | Title: Head of Research and Development and Chief Medical Officer | 11 Şubat 2021 A | 8.304 | 0 | 0 | $0 |
| Zoran Zdraveski | Title: Secretary and Chief Legal and Technology Operations Officer | 11 Şubat 2021 A | 133.010 | 0 | 0 | $0 |
| Christina K. Isacson | Chief Business Officer | 10 Şubat 2020 A | 83.786 | 0 | 0 | $0 |
| Jason Ryan | Title: Chief Operating and Financial Officer | 10 Şubat 2020 A | · | 0 | 0 | $0 |
| COOKE MICHAEL P. | Chief Scientific Officer | 02 Aralık 2019 S | 240.523 | 0 | 0 | $0 |
| Simon Read | Yönetim kurulu üyesi | 19 Ağustos 2026 M | 0 | 0 | 7 | $-630.786 |
| Anne Mcgeorge | Yönetim kurulu üyesi | 10 Ağustos 2026 M | 0 | 0 | 5 | $-844.822 |
| Jonathan Violin | Yönetim kurulu üyesi | 21 Mayıs 2026 A | · | 0 | 0 | $0 |
| Paula Soteropoulos | Yönetim kurulu üyesi | 21 Mayıs 2026 A | 0 | 0 | 3 | $-2.252.895 |
| Steven J. Romano | Yönetim kurulu üyesi | 21 Mayıs 2026 A | · | 0 | 0 | $0 |
| Alison Frances Lawton | Yönetim kurulu üyesi | 21 Mayıs 2026 A | · | 0 | 0 | $0 |
| MOULDER LEON O JR | Yönetim kurulu üyesi | 23 Mayıs 2024 A | 1.436.745 | 0 | 0 | $0 |
| Michael Vasconcelles | Yönetim kurulu üyesi | 15 Ağustos 2022 A | · | 0 | 0 | $0 |
| David Scadden | Yönetim kurulu üyesi | 28 Haziran 2022 A | 228.175 | 0 | 0 | $0 |
| Jeffrey W. Albers | Yönetim kurulu üyesi | 28 Haziran 2022 A | 4.152 | 0 | 0 | $0 |
| Thomas O Daniel | Yönetim kurulu üyesi | 28 Haziran 2022 A | 101.926 | 0 | 0 | $0 |
| Bruce Booth | Yönetim kurulu üyesi | 28 Haziran 2022 A | 1.250.000 | 0 | 0 | $0 |
| Amy L Ronneberg | Yönetim kurulu üyesi | 28 Haziran 2022 A | 593.611 | 0 | 0 | $0 |
| Alexis Borisy | Yönetim kurulu üyesi | 26 Ağustos 2021 J | 4.100 | 0 | 0 | $0 |
| Michael W Bonney | Yönetim kurulu üyesi | 01 Haziran 2021 A | 215.346 | 0 | 0 | $0 |
| Blake Byers | Yönetim kurulu üyesi | 05 Haziran 2020 A | 3.339.137 | 0 | 0 | $0 |
| Atlas Venture Fund X, L.P. | 10% sahip | 11 Şubat 2021 J | 3.148.399 | 0 | 0 | $0 |
| Sujay Kango | · | 21 Mayıs 2026 A | · | 0 | 0 | $0 |
| Caren Deardorf | · | 30 Kasım 2022 A | 19.762 | 0 | 0 | $0 |
| Kristen Stants | · | 30 Kasım 2022 A | 20.264 | 0 | 0 | $0 |
| Stephen F. Mahoney | · | 30 Kasım 2022 A | 17.264 | 0 | 0 | $0 |
| Thomas W. Beetham | · | 30 Kasım 2022 A | 19.897 | 0 | 0 | $0 |
| Jason Gardner | · | 30 Kasım 2022 A | 292.872 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 35 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| IBRN · iShares Trust | 5,04% | 3.652 SH | 11 Eylül 2026 | Günlük |
| LABU · Direxion Shares ETF Trust | 0,96% | 44.156 NS | 31 Temmuz 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,87% | 3.787 NS | 31 Temmuz 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,44% | 52.995 NS | 31 Temmuz 2026 | N-PORT |
| IWO · iShares Trust | 0,32% | 444.336 SH | 11 Eylül 2026 | Günlük |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,27% | 50.626 SH | 19 Ağustos 2026 | Günlük |
| PWS · Pacer Funds Trust | 0,27% | 603 NS | 31 Temmuz 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,18% | 1.463 NS | 31 Temmuz 2026 | N-PORT |
| FFSM · FIDELITY COVINGTON TRUST | 0,17% | 23.108 NS | 31 Temmuz 2026 | N-PORT |
| RSSL · Global X Funds | 0,16% | 22.655 NS | 31 Temmuz 2026 | N-PORT |
| IWM · iShares Trust | 0,16% | 1.209.461 SH | 11 Eylül 2026 | Günlük |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,16% | 10.325 NS | 31 Temmuz 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,15% | 29.943 SH | 19 Ağustos 2026 | Günlük |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,14% | 272.370 SH | 19 Ağustos 2026 | Günlük |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,14% | 17.898 NS | 31 Temmuz 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,09% | 4.800 NS | 31 Temmuz 2026 | N-PORT |
| ESML · iShares Trust | 0,06% | 16.364 SH | 11 Eylül 2026 | Günlük |
| FHLC · FIDELITY COVINGTON TRUST | 0,06% | 17.465 NS | 31 Temmuz 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,05% | 110.607 SH | 19 Ağustos 2026 | Günlük |
| DFAS · Dimensional ETF Trust | 0,05% | 71.218 NS | 31 Temmuz 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,04% | 457.520 SH | 19 Ağustos 2026 | Günlük |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,04% | 10.901 SH | 01 Ekim 2026 | Günlük |
| WSML · iShares Trust | 0,03% | 2.149 SH | 11 Eylül 2026 | Günlük |
| DCOR · Dimensional ETF Trust | 0,01% | 3.958 NS | 31 Temmuz 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 1.650.280 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 3.889 SH | 19 Ağustos 2026 | Günlük |
| IWV · iShares Trust | 0,01% | 12.690 SH | 11 Eylül 2026 | Günlük |
| DFAU · Dimensional ETF Trust | 0,01% | 7.297 NS | 31 Temmuz 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,01% | 27.975 NS | 31 Temmuz 2026 | N-PORT |
| ITOT · iShares Trust | 0,01% | 54.499 SH | 11 Eylül 2026 | Günlük |
| TILT · FlexShares Trust | 0,00% | 810 NS | 31 Temmuz 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 4.404 NS | 31 Temmuz 2026 | N-PORT |
| ISCB · iShares Trust | · | 1.709 SH | 11 Eylül 2026 | Günlük |
| ISCV · iShares Trust | · | 8.427 SH | 11 Eylül 2026 | Günlük |
| SMMV · iShares Trust | · | 2.457 SH | 19 Ağustos 2026 | Günlük |
DNTH Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 22 analist
AL
Medyan hedef
$134.00
+51,9%
10 45,5%
Güçlü Al
11 50,0%
Al
1 4,5%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
15 analist · 2026-10-03Ortalama hedef $140.80 +59,6%
← Tüm hedeflerin altında
Mevcut fiyat $88.21
Düşük$122.00
Ortalama$140.80
Yüksek$200.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| DNTH | $1.78B | -9.8 | -67.3% | -7973.3% | -40.8% | · |
| MIRM | $4.10B | -168.1 | 54.7% | -4.5% | -8.2% | · |
| TVTX | $3.47B | -131.8 | 110.5% | -5.2% | -34.6% | · |
| PTCT | $6.19B | 9.8 | 114.5% | 39.4% | -331.5% | · |
| ERAS | $1.06B | -8.5 | · | · | -35.7% | · |
| RLAY | $1.47B | -5.3 | 53.4% | -1800.6% | -44.9% | · |
| TNGX | $1.20B | -10.2 | 48.3% | -162.8% | -42.2% | · |
| VKTX | $4.04B | -11.0 | · | · | -47.3% | · |
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 4, 2026